EVALUATION OF THE CHROMATOGRAPHIC PROCEDURE FOR THE PREPARATION OF A HIGH-PURITY C1-ESTERASE INHIBITOR CONCENTRATE FROM CRYOSUPERNATANT PLASMA

被引:1
|
作者
TEH, LC
FROGER, M
机构
[1] Department of Blood Products Development, Auckland Regional Blood Centre, Auckland Hospital, Private Bag
来源
关键词
D O I
10.1016/0378-4347(92)80303-8
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
This report is an analysis of the parameters involved in the preparation of a C1-esterase inhibitor concentrate. We investigated ways to improve the purification by finding the optimal pH, ionic strength, and quantity of chromatographic media to use at each step. The optimisation of the process gave a greater than two-fold increase in both yield and purity over published methods. The product retained more than 50% activity upon dry heat-treatment at 80-degrees-C for 72 h, and the yield of the heat-treated product was 180 I.U./kg of plasma.
引用
收藏
页码:65 / 70
页数:6
相关论文
共 50 条
  • [31] Microheterogeneous changes of the C1-esterase inhibitor in plasma cannot predict operability, postoperative complications, or recurrence in cancer surgery
    Lasson, Å
    EUROPEAN JOURNAL OF SURGERY, 2001, 167 (10) : 734 - 741
  • [32] C1-esterase inhibitor and its effects on endotoxin-induced leukocyte adherence and plasma extravasation in postcapillary venules
    Robertshaw H.
    Critical Care, 1 (1):
  • [33] Purification of C1 Esterase Inhibitor from Human Plasma
    Verma, Sachin
    Makadia, Savan
    Dolia, Sheetal
    Pawar, Amit
    Kumar, Narendra
    PLASMATOLOGY, 2024, 18
  • [34] Preparation of high-purity and low-sulphur graphite from Woxna fine graphite concentrate by alkali roasting
    Lu, XJ
    Forssberg, E
    MINERALS ENGINEERING, 2002, 15 (10) : 755 - 757
  • [35] Subcutaneous C1-esterase inhibitor to prevent hereditary angioedema attacks: Safety findings from the COMPACT trial
    Li, H. Henry
    Mycroft, Sarah
    Christiansen, Sandra
    Wood, Daniel N.
    Feuersenger, Henrike
    Pawaskar, Dipti
    Jacobs, Iris
    ALLERGY AND ASTHMA PROCEEDINGS, 2018, 39 (05) : 365 - 370
  • [36] STRUCTURAL CHARACTERIZATION OF C1-ESTERASE INHIBITOR (C1BAR-INH) AND COMPARISON WITH DYSFUNCTIONAL PROTEINS FROM INDIVIDUALS WITH HANE
    HARRISON, RA
    ROSEN, FS
    MOLECULAR IMMUNOLOGY, 1982, 19 (11) : 1374 - 1374
  • [37] Plasma levels of prekallikrein, alpha-2-macroglobulin and C1-esterase inhibitor in patients with urticarial reaction to contrast media
    Mikkonen, R
    Aronen, HJ
    Kivisaari, L
    Piilonen, A
    Syrjala, M
    ACTA RADIOLOGICA, 1997, 38 (03) : 466 - 473
  • [38] Preparation of dense B4C ceramics by spark plasma sintering of high-purity nanoparticles
    Li, Penghui
    Ma, Mengdong
    Wu, Yingju
    Zhang, Xiang
    Chang, Yukai
    Zhuge, Zewen
    Sun, Lei
    Hu, Wentao
    Yu, Dongli
    Xu, Bo
    Zhao, Zhisheng
    Chen, Junyun
    He, Julong
    Tian, Yongjun
    JOURNAL OF THE EUROPEAN CERAMIC SOCIETY, 2021, 41 (07) : 3929 - 3936
  • [39] Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema
    Bork, Konrad
    IMMUNOTHERAPY, 2014, 6 (05) : 533 - 551
  • [40] Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
    Farkas, Henriette
    Levy, Donald
    Supina, Dylan
    Berger, Melvin
    Prusty, Subhransu
    Fridman, Moshe
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2020, 16 (01):